Literature DB >> 31026128

Determination of Dermal Pharmacokinetics by Microdialysis Sampling in Rats.

Nivea M F Voelkner1,2,3, Alexander Voelkner1, Hartmut Derendorf1.   

Abstract

The evaluation of absorption and availability at the site of action of a drug candidate is an important element of drug discovery and development, as clinical response is a function of the bioavailability of the active agent and its continued presence at the site of action. Evaluation of dermal pharmacokinetics facilitates the selection of new compounds or chemical structures for advancement as possible clinical candidates. An advantage of microdialysis is that it allows the measurement of compound concentrations at the site of action without disturbing the tissue milieu, making it possible to determine the relationship between this important variable and plasma concentrations of the agent. Described in this unit are laboratory protocols for performing dermal microdialysis experiments in rat for the purpose of defining the pharmacokinetics parameters of test agents.
© 2019 by John Wiley & Sons, Inc. © 2019 John Wiley & Sons, Inc.

Entities:  

Keywords:  dermal; microdialysis; pharmacokinetics; rats

Mesh:

Substances:

Year:  2019        PMID: 31026128     DOI: 10.1002/cpph.58

Source DB:  PubMed          Journal:  Curr Protoc Pharmacol        ISSN: 1934-8282


  1 in total

1.  Transdermal delivery of triptolide-phospholipid complex to treat rheumatoid arthritis.

Authors:  Xin-Yi Liu; Wen-Jun Pei; Ye-Zhen Wu; Fang-Li Ren; Si-Yu Yang; Xiu Wang
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.